Fourteen quinolone-resistant Pseudomonas putida isolates were recovered from imported frozen shrimp sold in the United States. Two isolates harbored plasmids with qnrA and qnrB genes. PCR and DNA sequencing of quinolone resistance-determining regions identified novel substitutions in GyrA (His1393Glu and Thr1283Ala) and GyrB (Thr4423Asn, Gly4703Ala, and Ile4873Pro) and previously reported substitutions in GyrB (Asp4893Glu) and ParC (Thr1053Pro).
The administration of quinolones, including nalidixic acid, oxolinic acid, enrofloxacin, norfloxacin, and ciprofloxacin, is a common practice in the shrimp-farming industry of developing countries, raising concern over the generation of multiresistant pathogenic bacteria (7, 11, 17) . Pseudomonas putida is a fastgrowing organism that is found in most temperate soil and water habitats and causes opportunistic infections in humans (2, 16, 19, 21) . This study describes the isolation, characterization, and detection of quinolone resistance mechanisms among P. putida isolates from imported shrimp.
Fourteen isolates of P. putida were isolated from a total of 10 samples of farm-raised, frozen, whole raw shrimp (Penaeus spp.) imported from India and purchased in retail stores (Little Rock, AR). One gram of shrimp was taken from three individual bags and homogenized in a stomacher with 10 ml of LB broth supplemented with 10 g/ml of nalidixic acid. The homogenate was enriched overnight at 37°C, and 100 to 200 l was subcultured onto TSAII plates (Becton Dickinson, Franklin Lakes, NJ). Isolates were confirmed as P. putida using VITEK 2 Gram-negative identification cards (bioMérieux, Durham, NC).
Pulsed-field gel electrophoresis (PFGE) analysis was performed using the Centers for Disease Control and Prevention procedure for Salmonella (http://www.cdc.gov/pulsenet /protocols.htm) to assess the genetic relatedness among the P. putida isolates recovered from the shrimp. Upon examination of PFGE patterns from SpeI restriction digests of DNA from the 14 P. putida strains, 10 clusters, each containing 14 to 20 restriction fragments, were apparent ( Fig. 1) .
The antimicrobial MICs for P. putida isolates were determined using the Sensititre automated antimicrobial susceptibility system according to the manufacturer's instructions (25) and interpreted based on the CLSI criteria (5) . When the ␤-lactam antimicrobial MICs were determined, all isolates were found resistant to cefoxitin, amoxicillin-clavulanic acid, ceftiofur, and ampicillin, and 8 of the 14 were resistant to ceftriaxone. When the aminoglycoside MICs were determined, the most isolates were found to be resistant to kanamycin (10/14 isolates), followed by streptomycin (9/14), amikacin (9/ 14), and gentamicin (1/14) . When the remaining antimicrobial MICs were determined, all isolates were found resistant to sulfisoxazole and 12 of the 14 were resistant to chloramphenicol, tetracycline, and trimethroprim-sulfamethoxazole. All isolates were resistant to nalidixic acid (Ն32 g/ml). Isolate PP3 exhibited intermediate resistance to ciprofloxacin (2 g/ml). All other isolates possessed various susceptibilities to ciprofloxacin, ranging from 0.25 to 1 g/ml. MICs determined for nalidixic acid and ciprofloxacin corresponding to the P. putida isolates grouped by PFGE patterns are displayed in Table 1 .
Limited studies with clinical P. putida isolates report that fluoroquinolone resistance involves point substitutions in DNA gyrase (gyrA and gyrB) and topoisomerase IV (parC) (12) . The amplification of quinolone resistance-determining regions (QRDRs) of gyrA (ϳ400 bp), gyrB (ϳ370 bp), and parC (ϳ180 bp) was carried out with previously published primers and amplification conditions (1) . DNA sequences were analyzed using the Pseudomonas Genome Database BLAST (28) .
Among the QRDRs, a majority (11/14) of the isolates contained a single replacement in GyrA (His-1393Glu). Isolate PP10 possessed an additional substitution in GyrA (Thr-1283Ala). For GyrB, a single substitution in PP3 (Asp-4893Glu) and three substitutions in PP16 (Thr-4423Asn, Gly-4703Ala, and Ile-4873Pro) were identified. Four of the isolates (PP21, PP24, PP25, and PP3) showed the replacement of Thr-105 by Pro in ParC. The substitutions detected in parC (Thr-1053Pro) and gyrB (Asp-4893Glu) agreed with findings from a previous study (12) . Our findings of amino acid changes in GyrA and GyrB differed somewhat from those of the previous study, which reported substitutions such as Thr-833Ile and Ser-1363Ala in GyrA and Glu-4693Asp in GyrB as possible substitutions contributing to high levels of fluoroquinolone resistance in human clinical isolates (12) . Moreover, our findings differed from GyrA substitutions in clinical isolates of Klebsiella pneumoniae, Escherichia coli, and Pseudomas aeruginosa, which have been shown to comprise Ser-833Ile, Ser-833Leu, and Thr-833Ile, respectively (4, 6, 27). A possible explanation for these discrepancies may be related to the sources of the isolates examined.
Interestingly, among the isolates in this study, PP3 exhibited a higher level of resistance to ciprofloxacin and possessed substitutions in gyrA, gyrB, and parC QRDRs, suggesting that, as found in other Enterobacteriaceae, high-level fluoroquinolone resistance may be associated with an increased number of substitutions present in the QRDRs (4, 9) .
In 1998, the first plasmid-mediated quinolone resistance gene (qnr) was discovered in a Klebsiella pneumoniae clinical isolate (18) . The qnr plasmid mediates low-level quinolone resistance and facilitates selection of higher-level resistance mutations (18) . The original qnr gene is now designated qnrA because two other plasmid-mediated quinolone resistance genes, qnrB (14) and qnrS (8) , possess mechanisms of action similar to that of qnrA in reducing fluoroquinolone activity. Plasmid extraction was performed using a QIAprep spin miniprep kit (Qiagen Inc., Valencia, CA) on the 14 P. putida isolates, but plasmids were recovered from 2, PP16 and PP19. PCR assays using previously published primers (29) detected qnrA and qnrB but not qnrS in both plasmids. Subsequently, PCR products for qnrA and qnrB were confirmed by restriction enzyme digestion and nucleotide sequencing.
Shewanella algae, a Gram-negative bacterium of marine and fresh water, was recently identified as a possible natural source of the plasmid-mediated quinolone resistance determinant QnrA (22) . Since quinolones are widely administered in the aquaculture of less developed countries, including the shrimp-farming industry (11) , it is possible at any concentration of quinolones, including low concentrations, to select for waterborne S. algae strains and promote the horizontal transfer of qnr genes to other bacteria, including P. putida found in water habitats. The generation of resistant pathogens in aquaculture environments is well documented (10, 15, 26, 31) , and evidence of transfer of resistanceencoding plasmids between bacteria found in aquaculture environments and humans has been shown (23) . Therefore, it can be speculated that the aquatic environment may play a possible role as a reservoir for antibiotic resistance genes. The transferability of plasmid-mediated quinolone resistance in P. putida strains harboring qnrA and qnrB genes was studied. Plasmids were transferred from P. putida to Escherichia coli J53 Azi r by conjugation using sodium azide (100 g/ml) for counterselection (13) . Ceftazidime (10 g/ml) was used in mating experiments instead of quinolones to avoid selection of quinolone resistance chromosomal mutations and because of the strong association between qnr genes and plasmids carrying cephalosporinase genes (3, 18, 20, 24) . To determine if quinolone resistance was transferred, the MICs for the donor, recipient, and transconjugant were measured and evaluated with 30-g nalidixic acid disks.
The MIC of nalidixic acid for transconjugants demonstrated an 8-fold increase, from 4 g/ml to 32 g/ml, over the MIC for the recipient E. coli strain J53. The MIC of ciprofloxacin for transconjugants demonstrated approximately a 4-fold increase, from 0.06 g/ml to 0.25 g/ml, over that for the recipient E. coli strain J53. The plasmid carrying qnrA and qnrB genes provided resistance to ciprofloxacin and nalidixic acid, a finding which agreed with earlier reports (14, 18) . The inhibition zones for recipient and donor strains were 18 mm and 8 mm, interpreted as susceptible and resistant, respectively. No zone of inhibition was present for the transconjugant, indicating that the recipient E. coli J53 had acquired quinolone resistance. Transconjugants also displayed decreased susceptibility to cefoxitin, chloramphenicol, amoxicillin-clavulanic acid, and ampicillin, suggesting that the plasmid may carry additional antibiotic resistance elements, as shown in previous studies (18, 29, 30) .
In summary, the findings of mutations in the bacterial enzymes DNA gyrase and topoisomerase IV and plasmid-borne qnr genes among P. putida isolates from shrimp in this study support reports that the use of antimicrobial agents in aquaculture might promote an increase in the frequency of antibiotic resistance genes in the microbiota of finfish, crustaceans, shellfish, and the environment.
